Opal Wealth Advisors LLC Purchases 221 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Opal Wealth Advisors LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the first quarter, HoldingsChannel.com reports. The firm owned 4,343 shares of the healthcare conglomerate’s stock after acquiring an additional 221 shares during the period. UnitedHealth Group accounts for approximately 0.7% of Opal Wealth Advisors LLC’s investment portfolio, making the stock its 18th biggest holding. Opal Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $2,275,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock valued at $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Capital International Investors increased its holdings in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. Northern Trust Corp boosted its position in UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. boosted its position in UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after buying an additional 861,854 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Kristen Gil bought 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares of the company’s stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on UNH. JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research report on Thursday, May 15th. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. Deutsche Bank Aktiengesellschaft dropped their target price on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. KeyCorp lowered their price objective on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a research report on Monday, June 2nd. Finally, TD Securities restated a “hold” rating and issued a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $426.52.

UnitedHealth Group Trading Down 1.6%

Shares of UNH stock opened at $313.39 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $284.28 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45. The stock has a 50 day simple moving average of $386.66 and a 200-day simple moving average of $474.19. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business posted $6.91 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.